Oscar Health (NYSE:OSCR) Raised to “Equal Weight” at Barclays

Oscar Health (NYSE:OSCR) was upgraded by equities research analysts at Barclays from an “underweight” rating to an “equal weight” rating in a research report issued on Monday, Marketbeat.com reports. The brokerage currently has a $18.00 price target on the stock, up from their previous price target of $13.00. Barclays‘s price objective would indicate a potential upside of 9.01% from the stock’s current price.

Other equities research analysts have also recently issued reports about the stock. The Goldman Sachs Group began coverage on shares of Oscar Health in a report on Tuesday, October 14th. They set a “neutral” rating and a $17.00 price target for the company. UBS Group boosted their price objective on Oscar Health from $11.00 to $12.00 and gave the stock a “sell” rating in a research report on Friday, November 7th. Wells Fargo & Company decreased their target price on Oscar Health from $14.00 to $11.00 and set an “underweight” rating for the company in a research note on Thursday, November 13th. Piper Sandler raised Oscar Health from a “neutral” rating to an “overweight” rating and lifted their price target for the stock from $13.00 to $25.00 in a research report on Tuesday, November 25th. Finally, Wall Street Zen lowered Oscar Health from a “hold” rating to a “sell” rating in a report on Saturday, December 6th. One equities research analyst has rated the stock with a Buy rating, seven have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Reduce” and a consensus price target of $16.29.

Oscar Health Trading Down 0.4%

Shares of OSCR stock opened at $16.51 on Monday. Oscar Health has a 12 month low of $11.20 and a 12 month high of $23.80. The company has a market cap of $4.37 billion, a PE ratio of -14.74 and a beta of 1.90. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67. The business’s 50 day moving average is $15.88 and its two-hundred day moving average is $16.99.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Thursday, November 6th. The company reported ($0.53) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.55) by $0.02. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The business had revenue of $2.93 billion during the quarter, compared to the consensus estimate of $3.09 billion. During the same period in the prior year, the firm earned ($0.22) EPS. Oscar Health’s quarterly revenue was up 23.2% compared to the same quarter last year. Equities analysts predict that Oscar Health will post 0.69 EPS for the current year.

Insider Transactions at Oscar Health

In other Oscar Health news, insider Janet Liang sold 7,338 shares of the firm’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total value of $121,737.42. Following the completion of the sale, the insider owned 172,527 shares in the company, valued at approximately $2,862,222.93. This trade represents a 4.08% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Richard Scott Blackley sold 25,135 shares of the business’s stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total value of $416,989.65. Following the sale, the chief financial officer owned 1,351,034 shares in the company, valued at approximately $22,413,654.06. This represents a 1.83% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 383,307 shares of company stock worth $5,919,555. Insiders own 25.11% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OSCR. Thrive Capital Management LLC grew its holdings in shares of Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the last quarter. Baird Financial Group Inc. acquired a new stake in shares of Oscar Health in the 1st quarter valued at approximately $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Oscar Health by 4.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company’s stock valued at $2,827,000 after buying an additional 8,879 shares during the period. NewEdge Advisors LLC grew its stake in Oscar Health by 89.7% in the first quarter. NewEdge Advisors LLC now owns 188,058 shares of the company’s stock valued at $2,465,000 after acquiring an additional 88,946 shares during the period. Finally, Dynamic Technology Lab Private Ltd bought a new stake in Oscar Health during the 1st quarter worth approximately $322,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.